Enzyre raised €12M in a Series A round in Nov 2022. The company is based in Nijmegen, Netherlands. Investors in the round: Demcon Investment, Dutch Government, i&i Biotech Fund and 3 others. Data as of 7 Aug 2026.
Reported in EUR — no conversion. €12M
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
